In the ever-evolving world of aesthetics, change is often a double-edged sword. Recently, Allergan, an AbbVie company, rolled out significant changes to their popular consumer loyalty program, Allē. While designed to enhance patient and practice outcomes, the new program, Allē Enhancements, sparked widespread discontent among medspa owners and injectors. The rollout was met with frustration, with many voicing concerns about its complexity, abrupt implementation, and increased burden on practices. Some practices even went as far as to discontinue offering Botox altogether.
But here’s the silver lining: Allergan has listened, and they’re taking action.
The Letter That Changes Things
Today, medspa owners received a heartfelt and candid letter from Carrie Strom, President of Global Allergan Aesthetics. In it, Allergan acknowledged the feedback they received and admitted their missteps. Here are the key takeaways:
Acknowledgment of Mistakes: Allergan recognized that the new program was overly complex and implemented too quickly, leading to disruption in practices.
Commitment to Change: In late January 2025, Allergan will revert to the original Allē program, putting an end to Allē Enhancements.
Enhanced Support: To make amends and rebuild trust, Allergan is introducing a significant Q1 investment, including double Allē points and increased consumer promotional offers.
Transparency and Partnership: The company promised clear communication with both practices and consumers as they transition back to the original Allē program.
Why This Matters
This decision is more than just a rollback of changes; it’s a testament to the power of collective feedback.
Thousands of medspa owners and injectors voiced their concerns, and Allergan responded with humility and a willingness to make things right.
In an industry where trust and collaboration are paramount, this move reinforces Allergan’s commitment to its partners.
Looking Ahead
The return to the original Allē program is just the beginning. The letter hints at ongoing efforts to ensure Allergan aligns with its mission: “Your Practice, Our Purpose.”
With upcoming promotions and investments, 2025 promises to be a year of renewed partnerships and growth opportunities for medspa owners and injectors.
Final Thoughts
While no company gets it right every time, Allergan’s response sets a strong example of listening, learning, and adapting.
As we step into the new year, this shift is a reminder of the importance of open communication between brands and the professionals they serve.
What are your thoughts on the changes? Will the return to the original Allē program ease the frustrations many experienced? Let’s continue the conversation and keep shaping the future of the aesthetics industry together.
Follow us on social and share your thoughts!
